Loading...

Phoenix Life Sciences International Limited

PLSIPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$-0.82(-99.99%)
U.S. Market opens in 6h 20m

Phoenix Life Sciences International Limited (PLSI) Stock Competitors & Peer Comparison

See (PLSI) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
PLSI$0.00-99.99%365.9KN/AN/AN/A
IPSEY$46.30+5.21%61.2B30.06$1.54+0.86%
MKKGY$25.22+3.53%54.8B18.12$1.39+2.00%
TKPHF$34.52+0.00%54.5B78.45$0.44+3.39%
MKGAF$122.45-4.16%53.2B17.63$6.94+2.04%
HLNCF$4.98+1.22%44.3B19.92$0.25+1.84%
SDZNY$78.20+3.47%33.8B37.35$2.09+0.94%
TEVJF$28.36+0.00%32.5B23.44$1.21N/A
SGIOF$23.60+10.02%20.1B18.73$1.26+1.64%
SGIOY$11.09+2.01%18.8B17.51$0.63+1.82%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

PLSI vs IPSEY Comparison April 2026

PLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PLSI stands at 365.9K. In comparison, IPSEY has a market cap of 61.2B. Regarding current trading prices, PLSI is priced at $0.00, while IPSEY trades at $46.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PLSI currently has a P/E ratio of N/A, whereas IPSEY's P/E ratio is 30.06. In terms of profitability, PLSI's ROE is -0.71%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, PLSI is less volatile compared to IPSEY. This indicates potentially lower risk in terms of short-term price fluctuations for PLSI.Check IPSEY's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions